EVA Therapeutics is primarily focused on rescuing premature newborn babies with respiratory distress syndrome by developing an unprecedented enteral ventilation technology. Learn more about the Osaka-based organization in this installment of our Let’s Interview Series.
Venture Valuation (VV) interviewed OZAKI Hiromu, Co-founder and CEO.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?